Skip to main content

Table 9 Kidney

From: Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis

Author Cases N Controlsa/Cohortb Source Population Exposure definition Exposure assessment Drug RR 95% CI
McLaughlin et al. [63] 495* 697a Population based More than 14 times per month for >36 months Personal Interview Aspirin (8%) 0.5 0.2–1.0
        1.8 0.7–4.1
McCredie et al. 1988[64] 360* 985a Population based >0.1 kg lifetime use Mailed questionnaire Aspirin (18%) 1.2 0.7–1.9
McCredie et al.1995[65] 1,732* 2,309a Population based >5 kg lifetime use Personal Interview Aspirin (5%) 1.2 0.9–1.7
Gago-Dominguez et al. [66] 1,201* 1,204a Population based Two or more times a week for 1 month or longer Personal Interview Aspirin (27%) 1.5 1.2–1.8
Paganini-Hill et al. [40] NR* 13,987b Cohort Daily use of aspirin for an undefined time Mailed Questionnaire Aspirin (16%) 6.3 2.0–20.0
Schreinemachers et al. [43] 32 12,668b Cohort Ever use of aspirin in the 30 days prior to start date Personal Interview Aspirin (59%) 0.60 0.29–1.24
  1. *Renal cell carcinoma only; Prevalence of exposure among controls/cohort; Male only; Female only.